Longmeng Li
UC Davis Comprehensive Cancer CenterUniversity of California, Davis(US)
Publications by Year
Research Areas
Nanoplatforms for cancer theranostics, Tuberculosis Research and Epidemiology, Immunotherapy and Immune Responses, Nanoparticle-Based Drug Delivery, RNA Interference and Gene Delivery
Most-Cited Works
- → Formulation in DDA-MPLA-TDB Liposome Enhances the Immunogenicity and Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection(2018)52 cited
- → A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors(2020)40 cited
- → A Multistage Subunit Vaccine Effectively Protects Mice Against Primary Progressive Tuberculosis, Latency and Reactivation(2017)38 cited
- → Tumor Receptor-Mediated In Vivo Modulation of the Morphology, Phototherapeutic Properties, and Pharmacokinetics of Smart Nanomaterials(2020)34 cited
- → A mitochondria-targeting lipid–small molecule hybrid nanoparticle for imaging and therapy in an orthotopic glioma model(2022)33 cited
- → Drug-drug conjugates self-assembled nanomedicines triggered photo−/immuno- therapy for synergistic cancer treatments(2023)32 cited
- → A transformable nanoplatform with multiple therapeutic and immunostimulatory properties for treatment of advanced cancers(2023)26 cited
- → Programmable Bispecific Nano-immunoengager That Captures T Cells and Reprograms Tumor Microenvironment(2022)25 cited
- → Label-Free Comparative Proteomics of Differentially Expressed Mycobacterium tuberculosis Protein in Rifampicin-Related Drug-Resistant Strains(2021)9 cited
- → Deep tumor-penetrating nano-delivery strategy to improve diagnosis and therapy in patient-derived xenograft (PDX) oral cancer model and patient tissue(2022)5 cited